ADMA Biologics Competitors and Similar CompaniesClear all

ADMA Biologics's competitors and similar companies include Autolus.
ADMA Biologics
ADMA Biologics
ADMA Biologics develops plasma-based biologics for the treatment and prevention of certain infectious diseases.
Autolus
Autolus
Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.
Founding Date
Founding Date
2004
Founding Date
2014
Type
Type
Public
Type
Public
Tags
Locations
Locations
Ramsey, US HQ
Boca Raton, US
Locations
London, GB HQ
London, GB
Employees
Employees
313
Employees
647
Valuation ($)
Valuation ($)
3.9 b
Valuation ($)
1.2 b

Financial

Revenue (est.)
Revenue (est.)
$510.2m (FY, 2025)
Revenue (est.)
$75.4m (FY, 2025)
Cost of goods
Cost of goods
$217.4m (FY, 2025)
Cost of goods
$86.6m (FY, 2025)
Gross profit
Gross profit
$292.8m (FY, 2025)
Gross profit
($10.7m) (FY, 2025)
Net income
Net income
$146.9m (FY, 2025)
Net income
($287.5m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 20m
Total funding raised
$ 281.7m
For sources of this data, please see the company profile

View Company Profiles

Autolus
HQ
London, GB
Employees
647

Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.

View company